4.56
price down icon7.69%   -0.38
after-market アフターアワーズ: 4.56
loading

Prime Medicine Inc (PRME) 最新ニュース

pulisher
08:31 AM

Prime Medicine appoints Matthew Hawryluk as chief business officer - Investing.com

08:31 AM
pulisher
08:14 AM

Prime Medicine, Inc. Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer - Quiver Quantitative

08:14 AM
pulisher
08:01 AM

Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer - The Globe and Mail

08:01 AM
pulisher
08:01 AM

Prime Medicine (NASDAQ: PRME) names Matthew Hawryluk CBO; >$2.5B in deals at Gritstone - Stock Titan

08:01 AM
pulisher
07:52 AM

Why Prime Medicine Inc. stock appeals to analystsMarket Movement Recap & Weekly Market Pulse Alerts - newser.com

07:52 AM
pulisher
07:31 AM

Will Prime Medicine Inc. stock outperform growth indexesMarket Growth Report & Low Drawdown Momentum Trade Ideas - newser.com

07:31 AM
pulisher
06:42 AM

Is Prime Medicine Inc. stock a buy in volatile markets2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com

06:42 AM
pulisher
04:19 AM

Price momentum metrics for Prime Medicine Inc. explainedMarket Risk Summary & Daily Market Momentum Tracking - newser.com

04:19 AM
pulisher
04:00 AM

Is Prime Medicine Inc. stock supported by strong fundamentalsJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com

04:00 AM
pulisher
01:19 AM

How Prime Medicine Inc. stock reacts to job market data2025 Momentum Check & Expert Curated Trade Setup Alerts - newser.com

01:19 AM
pulisher
01:18 AM

How Prime Medicine Inc. stock performs in weak economyJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com

01:18 AM
pulisher
12:51 PM

Momentum divergence signals in Prime Medicine Inc. chartMarket Trend Summary & Verified Swing Trading Watchlists - newser.com

12:51 PM
pulisher
Nov 02, 2025

Technical signs of recovery in Prime Medicine Inc.Market Risk Summary & Technical Confirmation Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Prime Medicine’s Price Target Revision Sparks Market Interest - StocksToTrade

Nov 02, 2025
pulisher
Nov 02, 2025

Prime Medicine Eyes Expansion with Strategic Partnerships and Investor Engagement - timothysykes.com

Nov 02, 2025
pulisher
Nov 02, 2025

Prime Medicine, Inc. (NYSE:PRME) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Prime Medicine’s Investor Activities and Upcoming Developments Boost Market Interest - StocksToTrade

Nov 01, 2025
pulisher
Nov 01, 2025

Prime Medicine Stock Poised for Strategic Growth With New Developments - timothysykes.com

Nov 01, 2025
pulisher
Nov 01, 2025

Prime Medicine (NASDAQ:PRME) Shares Up 9.9%Time to Buy? - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Prime Medicine (NYSE:PRME) Trading 11.9% HigherWhat's Next? - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Sumitomo Mitsui Trust Group Inc. Has $3.94 Million Position in Prime Medicine, Inc. $PRME - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

How institutional ownership impacts Prime Medicine Inc. stock2025 Big Picture & Safe Capital Growth Tips - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

PRME Stock Surge: A Buying Opportunity? - StocksToTrade

Oct 31, 2025
pulisher
Oct 31, 2025

Institutional investors in Prime Medicine, Inc. (NASDAQ:PRME) see US$174m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Does Prime Medicine Inc. qualify in momentum factor screeningEarnings Beat & Weekly High Potential Stock Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Combining price and volume data for Prime Medicine Inc.Portfolio Value Summary & Weekly Chart Analysis and Trade Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using economic indicators to assess Prime Medicine Inc. potentialWeekly Profit Report & AI Based Buy and Sell Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

IQ EQ FUND MANAGEMENT IRELAND Ltd Reduces Stock Holdings in Prime Medicine, Inc. $PRME - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 03:29:26 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Smart tools for monitoring Prime Medicine Inc.’s price actionJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Comparing Prime Medicine Inc. in custom built stock radarsMarket Performance Recap & Stock Portfolio Risk Management - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can Prime Medicine Inc. stock outperform in 2025 bull marketTrend Reversal & Daily Technical Forecast Reports - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Prime Medicine (NASDAQ: PRME) to file IND/CTA for PM577 in H1 2026 for Wilson’s Disease - Stock Titan

Oct 30, 2025
pulisher
Oct 29, 2025

News impact scoring models applied to Prime Medicine Inc.Weekly Trade Review & Real-Time Volume Analysis - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Prime Medicine Update Reveals Latest Trends in Healthcare Stocks - Kalkine Media

Oct 29, 2025
pulisher
Oct 29, 2025

Prime Medicine (NASDAQ:PRME) Trading Down 5.8%Here's Why - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Prime Medicine (NYSE:PRME) Stock Price Down 6.5%Here's Why - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

Prime Medicine (NYSE:PRME) Shares Gap DownShould You Sell? - MarketBeat

Oct 28, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
大文字化:     |  ボリューム (24 時間):